Integra LifeSciences Holdings Corporation:企業のM&A・事業提携・投資動向

◆英語タイトル:Integra LifeSciences Holdings Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C2084
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:114
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Integra LifeSciences Holdings Corporation – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Integra LifeSciences Holdings Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Integra LifeSciences Holdings Corporation since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Integra LifeSciences Holdings Corporation’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Integra LifeSciences Holdings Corporation. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Integra LifeSciences Holdings Corporation’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Integra LifeSciences Holdings Corporation and its subsidiaries since 2007.
- Information about key financial and legal advisors for Integra LifeSciences Holdings Corporation’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Integra LifeSciences Holdings Corporation’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
MERGERS & ACQUISITIONS 8
Mergers and Acquisitions – Overview 8
Mergers and Acquisitions – Deal reports 9
PARTNERSHIP 54
Partnership – Deal reports 54
CAPITAL RAISING 95
Capital Raising – Overview 95
Capital Raising – Deal reports 96
APPENDIX 104
Contact Us 104
About MarketLine Financial Deals Database 104
Deal Definition and Methodology 106
About MarketLine 113

List of Tables
Table 1: Integra LifeSciences Holdings Corporation M&A volume and value trend (2014-YTD2018)
Table 2: Integra LifeSciences Holdings Corporation M&A activity by geography (2014-YTD2018)
Table 3: Integra LifeSciences Holdings Corporation capital raising volume and value trend (2014-YTD2018)
Table 4: Integra LifeSciences Holdings Corporation capital raising by deal type (2014-YTD2018)

List of Figures
Figure 1: Integra LifeSciences Holdings Corporation M&A volume and value trend (2014-YTD2018)
Figure 2: Integra LifeSciences Holdings Corporation M&A activity by geography (2014-YTD2018)
Figure 3: Integra LifeSciences Holdings Corporation capital raising volume and value trend (2014-YTD2018)
Figure 4: Integra LifeSciences Holdings Corporation capital raising by deal type (2014-YTD2018)

★海外企業調査レポート[Integra LifeSciences Holdings Corporation:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Exiqon AS:医療機器:M&Aディール及び事業提携情報
    Summary Exiqon AS (Exiqon), a subsidiary of Qiagen NV, is a medical device company that develops, manufactures and markets molecular diagnostic test products. The company provides product categories such as microRNA research, incRNA research, mRNA research, DNA research, custom oligos and other reag …
  • Genworth Financial, Inc.:企業のM&A・事業提携・投資動向
    Genworth Financial, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Genworth Financial, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • HDI-Global SE:企業の戦略・SWOT・財務情報
    HDI-Global SE - Strategy, SWOT and Corporate Finance Report Summary HDI-Global SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Lakeview Hotel Investment Corp.:戦略・SWOT・企業財務分析
    Lakeview Hotel Investment Corp. - Strategy, SWOT and Corporate Finance Report Summary Lakeview Hotel Investment Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Xcel Energy Inc (XEL)-エネルギー分野:企業M&A・提携分析
    Summary Xcel Energy Inc. (Xcel Energy) is a vertically-integrated energy utility that generates, procures, transmits, distributes and sells electricity; and transports, stores and distributes natural gas through its subsidiaries. The company owns and operates generation assets utilizing diverse fuel …
  • API Technologies Corp.:戦略・SWOT・企業財務分析
    API Technologies Corp. - Strategy, SWOT and Corporate Finance Report Summary API Technologies Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • ARCA biopharma Inc (ABIO):企業の財務・戦略的SWOT分析
    Summary ARCA Biopharma Inc (ARCA), formerly Nuvelo Inc is a developer of genetically targeted therapies for cardiovascular diseases. The company’s product candidate include Gencaro, a mild vasodilator and investigational pharmacologically unique beta-blocker that is being developed for the treatment …
  • Kwang Dong Pharmaceutical Co Ltd (009290):製薬・医療:M&Aディール及び事業提携情報
    Summary Kwang Dong Pharmaceutical Co Ltd (Kwang Dong) is a drug manufacturer that develops, manufactures and supplies pharmaceuticals, health drinks and supplements. The company’s pharmaceutical products comprise OTC drugs, ETC drugs, general supplements, OTC drinks, consumer drinks, functional drin …
  • Altus Power America Management LLC:電力:M&Aディール及び事業提携情報
    Summary Altus Power America Management LLC (Altus Power) is a renewable energy company that offers private investments in clean energy projects and renewable energy certificates. The company constructs, owns, operates and manages clean energy systems on commercial buildings and properties, schools a …
  • Tredegar Corp (TG):企業の財務・戦略的SWOT分析
    Tredegar Corp (TG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • SQI Diagnostics Inc (SQD):医療機器:M&Aディール及び事業提携情報
    Summary SQI Diagnostics Inc (SQI Diagnostics) is a diagnostic company that provides in vitro diagnostic and pharmaceutical research products. The company provides products such as sqidworks, sqidlite and sqid-X. Its sqidworks system is used in labs. SQI Diagnostic’s sqidlite is a practical benchtop …
  • HemaCare Corp (HEMA)-医療機器分野:企業M&A・提携分析
    Summary HemaCare Corp (HemaCare) is a provider of biological blood products and services. The company offers primary blood cells and tissues derived from normal and mobilized peripheral blood, bone marrow and cord blood. It spans its expertise in isolations, custom cell collections and testing of pr …
  • L’Occitane International SA:企業の戦略・SWOT・財務分析
    L'Occitane International SA - Strategy, SWOT and Corporate Finance Report Summary L'Occitane International SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Pathogenetix Inc-医療機器分野:企業M&A・提携分析
    Summary Pathogenetix Inc (Pathogenetix), formerly US Genomics, a subsidiary of Toxic Reports LLC is a medical device company that develops an automated system for bacterial strain typing from complex samples. The company develops products and applications based on its proprietary genome sequence sca …
  • Pacific Coffee Company Ltd.:企業の戦略・SWOT・財務分析
    Pacific Coffee Company Ltd. - Strategy, SWOT and Corporate Finance Report Summary Pacific Coffee Company Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • SpectraCure AB:製薬・医療:M&Aディール及び事業提携情報
    Summary SpectraCure AB (SpectraCure) is a provider of cancer treatment solutions that offers medical device systems containing laser light sources and photoreactive drugs. The company develops and therapy system, commercializes photodynamic with IDOSE for tumors. It provides IDOSE platform which all …
  • Hovid Berhad (HOVID):企業の財務・戦略的SWOT分析
    Hovid Berhad (HOVID) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Genomic Vision SA (GV):医療機器:M&Aディール及び事業提携情報
    Summary Genomic Vision (Genomic) is a molecular diagnostics and technology company that develops and commercializes diagnostic tests for genetic diseases and cancers. The company’s portfolio comprises tests for breast cancer and colon cancer, diagnostic solution for facio-scapulo-humeral muscular dy …
  • Binggrae Co., Ltd.:企業の戦略・SWOT・財務情報
    Binggrae Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Binggrae Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • UPM-Kymmene Corporation:企業の戦略・SWOT・財務情報
    UPM-Kymmene Corporation - Strategy, SWOT and Corporate Finance Report Summary UPM-Kymmene Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆